Back to Search
Start Over
Figure S2 from Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 2: ALK secondary mutations (corresponding to main Figure 3).
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....ab28b15c018bb59556e50ced7cd06212
- Full Text :
- https://doi.org/10.1158/1078-0432.22474065.v1